Seeing Is Believing
CYT is currently covered by 4 analysts with an average price target of $5.7. This is a potential upside of $2.68 (88.74%) from yesterday's end of day stock price of $3.02.
Cyteir Therapeutics's activity chart (see below) currently has 4 price targets and 10 ratings on display. The stock rating distribution of CYT is 40% BUY, 40% HOLD and 20% SELL.
Analysts average stock forecasts to be materialized ratio is 20.83% with an average time for these price targets to be met of 53.25 days.
Highest price target for CYT is $3, Lowest price target is $2, average price target is $5.7.
Most recent stock forecast was given by TAZEEN AHMAD from BAML on 05-Jan-2024. First documented stock forecast 13-Jul-2021.
Currently out of the existing stock ratings of CYT, 2 are a BUY (40%), 2 are a HOLD (40%), 1 are a SELL (20%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
2
$-1.02 (-33.77%)
23
2 months 24 days ago
0/2 (0%)
$-1.03 (-33.99%)
Buy
3
$-0.02 (-0.66%)
10 months 17 days ago
1/2 (50%)
$0.6 (25.00%)
144
Hold
2
$-1.02 (-33.77%)
4
1 years 1 months 26 days ago
1/3 (33.33%)
$0.31 (18.34%)
69
Hold
30
1 years 2 months 9 days ago
0/1 (0%)
$10.84 (56.58%)
What is CYT (Cyteir Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CYT (Cyteir Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CYT (Cyteir Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CYT (Cyteir Therapeutics)?
Which analyst is the currently most bullish on CYT (Cyteir Therapeutics)?
Which analyst is the currently most reserved on CYT (Cyteir Therapeutics)?